Bavencio and Back pain aggravated - a phase IV clinical study of FDA data

Summary:

Back pain aggravated is reported as a side effect among people who take Bavencio (avelumab), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Axitinib, and have Transitional cell carcinoma.

The phase IV clinical study analyzes which people have Back pain aggravated when taking Bavencio. It is created by eHealthMe based on reports of 1,606 people who have side effects when taking Bavencio from the FDA, and is updated regularly.

What is Bavencio?

Bavencio has active ingredients of avelumab. eHealthMe is studying from 1,606 Bavencio users. Check the latest studies of Bavencio.

What is Back pain aggravated?

Back pain aggravated is found to be associated with 3,359 drugs and 2,100 conditions by eHealthMe. Check the latest studies of Back pain aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

1,606 people reported to have side effects when taking Bavencio.
Among them, 22 people (1.37%) have Back pain aggravated.

Could Bavencio cause Back pain aggravated?

Among these 22 people:

How long have people been on Bavencio when they have Back pain aggravated? *

What is the gender of people who have Back pain aggravated when taking Bavencio? *

female: 11.11 %
male: 88.89 %

What is the age of people who have Back pain aggravated when taking Bavencio? *

What are other drugs people take besides Bavencio? *

What are other side effects people have besides Back pain aggravated? *

Dyspnea (difficult or laboured breathing): 4 people, 18.18%
Chills (felling of cold): 3 people, 13.64%
Fatigue (feeling of tiredness): 3 people, 13.64%
Dizziness: 3 people, 13.64%
Nausea (feeling of having an urge to vomit): 3 people, 13.64%
Diarrhea: 3 people, 13.64%
Rashes (redness): 3 people, 13.64%
Weight Increased: 2 people, 9.09%
Hypotension (abnormally low blood pressure): 2 people, 9.09%
Weight Decreased: 2 people, 9.09%

What are the existing conditions these people have? *

Transitional Cell Carcinoma (cancer tumour inner most layer of urinary system): 6 people, 27.27%
Neuroendocrine Carcinoma Of The Skin (a rare type of cancer that forms on or just beneath the skin, usually in parts of the body that have been exposed to the sun): 5 people, 22.73%
Renal Neoplasm (kidney tumour): 1 person, 4.55%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Bavencio and have Back pain aggravated?

- Check whether Back pain aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bavencio:

Bavencio (1,606 reports)

Browse all side effects of Bavencio:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Back pain aggravated:

Back pain aggravated (3,359 drugs)

Browse all the conditions that are associated with Back pain aggravated:

Back pain aggravated (2,100 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on avelumab (the active ingredients of Bavencio) and Bavencio (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.